title: Travel-acquired salmonellosis due to Salmonella Kentucky resistant to ciprofloxacin, ceftriaxone and co-trimoxazole and associated with treatment failure.
authors: Jean-Marc
authors: JM
authors: Collard
authors: Sammy
authors: S
authors: Place
authors: Olivier
authors: O
authors: Denis
authors: Hector
authors: H
authors: Rodriguez-Villalobos
authors: Martine
authors: M
authors: Vrints
authors: François-Xavier
authors: FX
authors: Weill
authors: Sylvie
authors: S
authors: Baucheron
authors: Axel
authors: A
authors: Cloeckaert
authors: Marc
authors: M
authors: Struelens
authors: Sophie
authors: S
authors: Bertrand
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002443:Ceftriaxone / Q000494:pharmacology; D002939:Ciprofloxacin / Q000494:pharmacology; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D012480:Salmonella Infections / Q000188:drug therapy* / Q000382:microbiology; D019779:Salmonella enterica / Q000145:classification / Q000187:drug effects*; D012703:Serotyping; D014195:Travel; D017211:Treatment Failure; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000494:pharmacology
chemical_list: D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin; D002443:Ceftriaxone; D015662:Trimethoprim, Sulfamethoxazole Drug Combination